KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLong-Term Debt RepaymentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)R&D In ProcessShares IssuedShares Repurchased
Ratios

Gilead Sciences (GILD) Accumulated Depreciation & Amortization (2016 - 2025)

Historic Accumulated Depreciation & Amortization for Gilead Sciences (GILD) over the last 17 years, with Q3 2025 value amounting to $2.7 billion.

  • Gilead Sciences' Accumulated Depreciation & Amortization changed N/A to $2.7 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $2.7 billion, marking a year-over-year change of. This contributed to the annual value of $2.5 billion for FY2024, which is 85.75% up from last year.
  • According to the latest figures from Q3 2025, Gilead Sciences' Accumulated Depreciation & Amortization is $2.7 billion.
  • Gilead Sciences' 5-year Accumulated Depreciation & Amortization high stood at $2.7 billion for Q3 2025, and its period low was $1.9 billion during Q4 2021.
  • For the 5-year period, Gilead Sciences' Accumulated Depreciation & Amortization averaged around $2.4 billion, with its median value being $2.5 billion (2024).
  • Its Accumulated Depreciation & Amortization has fluctuated over the past 5 years, first skyrocketed by 1547.81% in 2022, then soared by 85.75% in 2024.
  • Quarter analysis of 5 years shows Gilead Sciences' Accumulated Depreciation & Amortization stood at $1.9 billion in 2021, then rose by 15.48% to $2.2 billion in 2022, then increased by 12.03% to $2.4 billion in 2023, then grew by 0.86% to $2.5 billion in 2024, then grew by 9.03% to $2.7 billion in 2025.
  • Its Accumulated Depreciation & Amortization stands at $2.7 billion for Q3 2025, versus $2.6 billion for Q2 2025 and $2.5 billion for Q1 2025.